Global Diagnostic Biomarkers Market Insights, Forecast to 2034
Market Analysis and InsightsGlobal Diagnostic Biomarkers Market
Global Diagnostic Biomarkers market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Diagnostic Biomarkers industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Diagnostic Biomarkers market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Diagnostic Biomarkers market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
Qiagen N.V.
Perkinelmer, Inc.
Merck Millipore
Bio-Rad Laboratories, Inc.
Enzo Biochem, Inc.
EKF Diagnostics Holdings, Inc.
Meso Scale Diagnostics, LLC.
Biosims Technologies Sas
Cisbio Bioassays
Signosis, Inc
Banyan Biomarkers, Inc
Biomedical Corp
Segment by Type
Safety Biomarkers
Efficacy Biomarkers
Validation Biomarkers
Segment by Application
Hospitals
Cancer Research Institutes
Diagnostic Labs
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Diagnostic Biomarkers introduction, etc. Diagnostic Biomarkers Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Diagnostic Biomarkers
Chapter 13Methodology and Data Sources adopted by MRAResearch
Table of Content
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diagnostic Biomarkers Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Safety Biomarkers
1.2.3 Efficacy Biomarkers
1.2.4 Validation Biomarkers
1.3 Market by Application
1.3.1 Global Diagnostic Biomarkers Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Cancer Research Institutes
1.3.4 Diagnostic Labs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Diagnostic Biomarkers Market Perspective (2018-2033)
2.2 Global Diagnostic Biomarkers Growth Trends by Region
2.2.1 Diagnostic Biomarkers Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Diagnostic Biomarkers Historic Market Size by Region (2018-2023)
2.2.3 Diagnostic Biomarkers Forecasted Market Size by Region (2024-2033)
2.3 Diagnostic Biomarkers Market Dynamics
2.3.1 Diagnostic Biomarkers Industry Trends
2.3.2 Diagnostic Biomarkers Market Drivers
2.3.3 Diagnostic Biomarkers Market Challenges
2.3.4 Diagnostic Biomarkers Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Diagnostic Biomarkers by Players
3.1.1 Global Diagnostic Biomarkers Revenue by Players (2018-2023)
3.1.2 Global Diagnostic Biomarkers Revenue Market Share by Players (2018-2023)
3.2 Global Diagnostic Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Diagnostic Biomarkers, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Diagnostic Biomarkers Market Concentration Ratio
3.4.1 Global Diagnostic Biomarkers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diagnostic Biomarkers Revenue in 2022
3.5 Global Key Players of Diagnostic Biomarkers Head office and Area Served
3.6 Global Key Players of Diagnostic Biomarkers, Product and Application
3.7 Global Key Players of Diagnostic Biomarkers, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Diagnostic Biomarkers Breakdown Data by Type
4.1 Global Diagnostic Biomarkers Historic Market Size by Type (2018-2023)
4.2 Global Diagnostic Biomarkers Forecasted Market Size by Type (2024-2033)
5 Diagnostic Biomarkers Breakdown Data by Application
5.1 Global Diagnostic Biomarkers Historic Market Size by Application (2018-2023)
5.2 Global Diagnostic Biomarkers Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Diagnostic Biomarkers Market Size (2018-2033)
6.2 North America Diagnostic Biomarkers Market Size by Type
6.2.1 North America Diagnostic Biomarkers Market Size by Type (2018-2023)
6.2.2 North America Diagnostic Biomarkers Market Size by Type (2024-2033)
6.2.3 North America Diagnostic Biomarkers Market Share by Type (2018-2033)
6.3 North America Diagnostic Biomarkers Market Size by Application
6.3.1 North America Diagnostic Biomarkers Market Size by Application (2018-2023)
6.3.2 North America Diagnostic Biomarkers Market Size by Application (2024-2033)
6.3.3 North America Diagnostic Biomarkers Market Share by Application (2018-2033)
6.4 North America Diagnostic Biomarkers Market Size by Country
6.4.1 North America Diagnostic Biomarkers Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Diagnostic Biomarkers Market Size by Country (2018-2023)
6.4.3 North America Diagnostic Biomarkers Market Size by Country (2024-2033)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Diagnostic Biomarkers Market Size (2018-2033)
7.2 Europe Diagnostic Biomarkers Market Size by Type
7.2.1 Europe Diagnostic Biomarkers Market Size by Type (2018-2023)
7.2.2 Europe Diagnostic Biomarkers Market Size by Type (2024-2033)
7.2.3 Europe Diagnostic Biomarkers Market Share by Type (2018-2033)
7.3 Europe Diagnostic Biomarkers Market Size by Application
7.3.1 Europe Diagnostic Biomarkers Market Size by Application (2018-2023)
7.3.2 Europe Diagnostic Biomarkers Market Size by Application (2024-2033)
7.3.3 Europe Diagnostic Biomarkers Market Share by Application (2018-2033)
7.4 Europe Diagnostic Biomarkers Market Size by Country
7.4.1 Europe Diagnostic Biomarkers Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Diagnostic Biomarkers Market Size by Country (2018-2023)
7.4.3 Europe Diagnostic Biomarkers Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Diagnostic Biomarkers Market Size (2018-2033)
8.2 China Diagnostic Biomarkers Market Size by Type
8.2.1 China Diagnostic Biomarkers Market Size by Type (2018-2023)
8.2.2 China Diagnostic Biomarkers Market Size by Type (2024-2033)
8.2.3 China Diagnostic Biomarkers Market Share by Type (2018-2033)
8.3 China Diagnostic Biomarkers Market Size by Application
8.3.1 China Diagnostic Biomarkers Market Size by Application (2018-2023)
8.3.2 China Diagnostic Biomarkers Market Size by Application (2024-2033)
8.3.3 China Diagnostic Biomarkers Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Diagnostic Biomarkers Market Size (2018-2033)
9.2 Asia Diagnostic Biomarkers Market Size by Type
9.2.1 Asia Diagnostic Biomarkers Market Size by Type (2018-2023)
9.2.2 Asia Diagnostic Biomarkers Market Size by Type (2024-2033)
9.2.3 Asia Diagnostic Biomarkers Market Share by Type (2018-2033)
9.3 Asia Diagnostic Biomarkers Market Size by Application
9.3.1 Asia Diagnostic Biomarkers Market Size by Application (2018-2023)
9.3.2 Asia Diagnostic Biomarkers Market Size by Application (2024-2033)
9.3.3 Asia Diagnostic Biomarkers Market Share by Application (2018-2033)
9.4 Asia Diagnostic Biomarkers Market Size by Region
9.4.1 Asia Diagnostic Biomarkers Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Diagnostic Biomarkers Market Size by Region (2018-2023)
9.4.3 Asia Diagnostic Biomarkers Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Diagnostic Biomarkers Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Diagnostic Biomarkers Market Size by Type
10.2.1 Middle East, Africa, and Latin America Diagnostic Biomarkers Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Diagnostic Biomarkers Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Diagnostic Biomarkers Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Diagnostic Biomarkers Market Size by Application
10.3.1 Middle East, Africa, and Latin America Diagnostic Biomarkers Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Diagnostic Biomarkers Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Diagnostic Biomarkers Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Diagnostic Biomarkers Market Size by Country
10.4.1 Middle East, Africa, and Latin America Diagnostic Biomarkers Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Diagnostic Biomarkers Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Diagnostic Biomarkers Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Qiagen N.V.
11.1.1 Qiagen N.V. Company Details
11.1.2 Qiagen N.V. Business Overview
11.1.3 Qiagen N.V. Diagnostic Biomarkers Introduction
11.1.4 Qiagen N.V. Revenue in Diagnostic Biomarkers Business (2018-2023)
11.1.5 Qiagen N.V. Recent Developments
11.2 Perkinelmer, Inc.
11.2.1 Perkinelmer, Inc. Company Details
11.2.2 Perkinelmer, Inc. Business Overview
11.2.3 Perkinelmer, Inc. Diagnostic Biomarkers Introduction
11.2.4 Perkinelmer, Inc. Revenue in Diagnostic Biomarkers Business (2018-2023)
11.2.5 Perkinelmer, Inc. Recent Developments
11.3 Merck Millipore
11.3.1 Merck Millipore Company Details
11.3.2 Merck Millipore Business Overview
11.3.3 Merck Millipore Diagnostic Biomarkers Introduction
11.3.4 Merck Millipore Revenue in Diagnostic Biomarkers Business (2018-2023)
11.3.5 Merck Millipore Recent Developments
11.4 Bio-Rad Laboratories, Inc.
11.4.1 Bio-Rad Laboratories, Inc. Company Details
11.4.2 Bio-Rad Laboratories, Inc. Business Overview
11.4.3 Bio-Rad Laboratories, Inc. Diagnostic Biomarkers Introduction
11.4.4 Bio-Rad Laboratories, Inc. Revenue in Diagnostic Biomarkers Business (2018-2023)
11.4.5 Bio-Rad Laboratories, Inc. Recent Developments
11.5 Enzo Biochem, Inc.
11.5.1 Enzo Biochem, Inc. Company Details
11.5.2 Enzo Biochem, Inc. Business Overview
11.5.3 Enzo Biochem, Inc. Diagnostic Biomarkers Introduction
11.5.4 Enzo Biochem, Inc. Revenue in Diagnostic Biomarkers Business (2018-2023)
11.5.5 Enzo Biochem, Inc. Recent Developments
11.6 EKF Diagnostics Holdings, Inc.
11.6.1 EKF Diagnostics Holdings, Inc. Company Details
11.6.2 EKF Diagnostics Holdings, Inc. Business Overview
11.6.3 EKF Diagnostics Holdings, Inc. Diagnostic Biomarkers Introduction
11.6.4 EKF Diagnostics Holdings, Inc. Revenue in Diagnostic Biomarkers Business (2018-2023)
11.6.5 EKF Diagnostics Holdings, Inc. Recent Developments
11.7 Meso Scale Diagnostics, LLC.
11.7.1 Meso Scale Diagnostics, LLC. Company Details
11.7.2 Meso Scale Diagnostics, LLC. Business Overview
11.7.3 Meso Scale Diagnostics, LLC. Diagnostic Biomarkers Introduction
11.7.4 Meso Scale Diagnostics, LLC. Revenue in Diagnostic Biomarkers Business (2018-2023)
11.7.5 Meso Scale Diagnostics, LLC. Recent Developments
11.8 Biosims Technologies Sas
11.8.1 Biosims Technologies Sas Company Details
11.8.2 Biosims Technologies Sas Business Overview
11.8.3 Biosims Technologies Sas Diagnostic Biomarkers Introduction
11.8.4 Biosims Technologies Sas Revenue in Diagnostic Biomarkers Business (2018-2023)
11.8.5 Biosims Technologies Sas Recent Developments
11.9 Cisbio Bioassays
11.9.1 Cisbio Bioassays Company Details
11.9.2 Cisbio Bioassays Business Overview
11.9.3 Cisbio Bioassays Diagnostic Biomarkers Introduction
11.9.4 Cisbio Bioassays Revenue in Diagnostic Biomarkers Business (2018-2023)
11.9.5 Cisbio Bioassays Recent Developments
11.10 Signosis, Inc
11.10.1 Signosis, Inc Company Details
11.10.2 Signosis, Inc Business Overview
11.10.3 Signosis, Inc Diagnostic Biomarkers Introduction
11.10.4 Signosis, Inc Revenue in Diagnostic Biomarkers Business (2018-2023)
11.10.5 Signosis, Inc Recent Developments
11.11 Banyan Biomarkers, Inc
11.11.1 Banyan Biomarkers, Inc Company Details
11.11.2 Banyan Biomarkers, Inc Business Overview
11.11.3 Banyan Biomarkers, Inc Diagnostic Biomarkers Introduction
11.11.4 Banyan Biomarkers, Inc Revenue in Diagnostic Biomarkers Business (2018-2023)
11.11.5 Banyan Biomarkers, Inc Recent Developments
11.12 Biomedical Corp
11.12.1 Biomedical Corp Company Details
11.12.2 Biomedical Corp Business Overview
11.12.3 Biomedical Corp Diagnostic Biomarkers Introduction
11.12.4 Biomedical Corp Revenue in Diagnostic Biomarkers Business (2018-2023)
11.12.5 Biomedical Corp Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figure
List of Tables
Table 1. Global Diagnostic Biomarkers Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Safety Biomarkers
Table 3. Key Players of Efficacy Biomarkers
Table 4. Key Players of Validation Biomarkers
Table 5. Global Diagnostic Biomarkers Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 6. Global Diagnostic Biomarkers Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Diagnostic Biomarkers Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Diagnostic Biomarkers Market Share by Region (2018-2023)
Table 9. Global Diagnostic Biomarkers Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Diagnostic Biomarkers Market Share by Region (2024-2033)
Table 11. Diagnostic Biomarkers Market Trends
Table 12. Diagnostic Biomarkers Market Drivers
Table 13. Diagnostic Biomarkers Market Challenges
Table 14. Diagnostic Biomarkers Market Restraints
Table 15. Global Diagnostic Biomarkers Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Diagnostic Biomarkers Revenue Share by Players (2018-2023)
Table 17. Global Top Diagnostic Biomarkers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Biomarkers as of 2022)
Table 18. Global Diagnostic Biomarkers Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by Diagnostic Biomarkers Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of Diagnostic Biomarkers, Headquarters and Area Served
Table 21. Global Key Players of Diagnostic Biomarkers, Product and Application
Table 22. Global Key Players of Diagnostic Biomarkers, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Diagnostic Biomarkers Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Diagnostic Biomarkers Revenue Market Share by Type (2018-2023)
Table 26. Global Diagnostic Biomarkers Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Diagnostic Biomarkers Revenue Market Share by Type (2024-2033)
Table 28. Global Diagnostic Biomarkers Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Diagnostic Biomarkers Revenue Share by Application (2018-2023)
Table 30. Global Diagnostic Biomarkers Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Diagnostic Biomarkers Revenue Share by Application (2024-2033)
Table 32. North America Diagnostic Biomarkers Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America Diagnostic Biomarkers Market Size by Type (2024-2033) & (US$ Million)
Table 34. North America Diagnostic Biomarkers Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America Diagnostic Biomarkers Market Size by Application (2024-2033) & (US$ Million)
Table 36. North America Diagnostic Biomarkers Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. North America Diagnostic Biomarkers Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Diagnostic Biomarkers Market Size by Country (2024-2033) & (US$ Million)
Table 39. Europe Diagnostic Biomarkers Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe Diagnostic Biomarkers Market Size by Type (2024-2033) & (US$ Million)
Table 41. Europe Diagnostic Biomarkers Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe Diagnostic Biomarkers Market Size by Application (2024-2033) & (US$ Million)
Table 43. Europe Diagnostic Biomarkers Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Europe Diagnostic Biomarkers Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe Diagnostic Biomarkers Market Size by Country (2024-2033) & (US$ Million)
Table 46. China Diagnostic Biomarkers Market Size by Type (2018-2023) & (US$ Million)
Table 47. China Diagnostic Biomarkers Market Size by Type (2024-2033) & (US$ Million)
Table 48. China Diagnostic Biomarkers Market Size by Application (2018-2023) & (US$ Million)
Table 49. China Diagnostic Biomarkers Market Size by Application (2024-2033) & (US$ Million)
Table 50. Asia Diagnostic Biomarkers Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia Diagnostic Biomarkers Market Size by Type (2024-2033) & (US$ Million)
Table 52. Asia Diagnostic Biomarkers Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia Diagnostic Biomarkers Market Size by Application (2024-2033) & (US$ Million)
Table 54. Asia Diagnostic Biomarkers Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 55. Asia Diagnostic Biomarkers Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia Diagnostic Biomarkers Market Size by Region (2024-2033) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Diagnostic Biomarkers Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Diagnostic Biomarkers Market Size by Type (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Diagnostic Biomarkers Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Diagnostic Biomarkers Market Size by Application (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Diagnostic Biomarkers Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 62. Middle East, Africa, and Latin America Diagnostic Biomarkers Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Diagnostic Biomarkers Market Size by Country (2024-2033) & (US$ Million)
Table 64. Qiagen N.V. Company Details
Table 65. Qiagen N.V. Business Overview
Table 66. Qiagen N.V. Diagnostic Biomarkers Product
Table 67. Qiagen N.V. Revenue in Diagnostic Biomarkers Business (2018-2023) & (US$ Million)
Table 68. Qiagen N.V. Recent Developments
Table 69. Perkinelmer, Inc. Company Details
Table 70. Perkinelmer, Inc. Business Overview
Table 71. Perkinelmer, Inc. Diagnostic Biomarkers Product
Table 72. Perkinelmer, Inc. Revenue in Diagnostic Biomarkers Business (2018-2023) & (US$ Million)
Table 73. Perkinelmer, Inc. Recent Developments
Table 74. Merck Millipore Company Details
Table 75. Merck Millipore Business Overview
Table 76. Merck Millipore Diagnostic Biomarkers Product
Table 77. Merck Millipore Revenue in Diagnostic Biomarkers Business (2018-2023) & (US$ Million)
Table 78. Merck Millipore Recent Developments
Table 79. Bio-Rad Laboratories, Inc. Company Details
Table 80. Bio-Rad Laboratories, Inc. Business Overview
Table 81. Bio-Rad Laboratories, Inc. Diagnostic Biomarkers Product
Table 82. Bio-Rad Laboratories, Inc. Revenue in Diagnostic Biomarkers Business (2018-2023) & (US$ Million)
Table 83. Bio-Rad Laboratories, Inc. Recent Developments
Table 84. Enzo Biochem, Inc. Company Details
Table 85. Enzo Biochem, Inc. Business Overview
Table 86. Enzo Biochem, Inc. Diagnostic Biomarkers Product
Table 87. Enzo Biochem, Inc. Revenue in Diagnostic Biomarkers Business (2018-2023) & (US$ Million)
Table 88. Enzo Biochem, Inc. Recent Developments
Table 89. EKF Diagnostics Holdings, Inc. Company Details
Table 90. EKF Diagnostics Holdings, Inc. Business Overview
Table 91. EKF Diagnostics Holdings, Inc. Diagnostic Biomarkers Product
Table 92. EKF Diagnostics Holdings, Inc. Revenue in Diagnostic Biomarkers Business (2018-2023) & (US$ Million)
Table 93. EKF Diagnostics Holdings, Inc. Recent Developments
Table 94. Meso Scale Diagnostics, LLC. Company Details
Table 95. Meso Scale Diagnostics, LLC. Business Overview
Table 96. Meso Scale Diagnostics, LLC. Diagnostic Biomarkers Product
Table 97. Meso Scale Diagnostics, LLC. Revenue in Diagnostic Biomarkers Business (2018-2023) & (US$ Million)
Table 98. Meso Scale Diagnostics, LLC. Recent Developments
Table 99. Biosims Technologies Sas Company Details
Table 100. Biosims Technologies Sas Business Overview
Table 101. Biosims Technologies Sas Diagnostic Biomarkers Product
Table 102. Biosims Technologies Sas Revenue in Diagnostic Biomarkers Business (2018-2023) & (US$ Million)
Table 103. Biosims Technologies Sas Recent Developments
Table 104. Cisbio Bioassays Company Details
Table 105. Cisbio Bioassays Business Overview
Table 106. Cisbio Bioassays Diagnostic Biomarkers Product
Table 107. Cisbio Bioassays Revenue in Diagnostic Biomarkers Business (2018-2023) & (US$ Million)
Table 108. Cisbio Bioassays Recent Developments
Table 109. Signosis, Inc Company Details
Table 110. Signosis, Inc Business Overview
Table 111. Signosis, Inc Diagnostic Biomarkers Product
Table 112. Signosis, Inc Revenue in Diagnostic Biomarkers Business (2018-2023) & (US$ Million)
Table 113. Signosis, Inc Recent Developments
Table 114. Banyan Biomarkers, Inc Company Details
Table 115. Banyan Biomarkers, Inc Business Overview
Table 116. Banyan Biomarkers, Inc Diagnostic Biomarkers Product
Table 117. Banyan Biomarkers, Inc Revenue in Diagnostic Biomarkers Business (2018-2023) & (US$ Million)
Table 118. Banyan Biomarkers, Inc Recent Developments
Table 119. Biomedical Corp Company Details
Table 120. Biomedical Corp Business Overview
Table 121. Biomedical Corp Diagnostic Biomarkers Product
Table 122. Biomedical Corp Revenue in Diagnostic Biomarkers Business (2018-2023) & (US$ Million)
Table 123. Biomedical Corp Recent Developments
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Diagnostic Biomarkers Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Diagnostic Biomarkers Market Share by Type: 2022 VS 2033
Figure 3. Safety Biomarkers Features
Figure 4. Efficacy Biomarkers Features
Figure 5. Validation Biomarkers Features
Figure 6. Global Diagnostic Biomarkers Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 7. Global Diagnostic Biomarkers Market Share by Application: 2022 VS 2033
Figure 8. Hospitals Case Studies
Figure 9. Cancer Research Institutes Case Studies
Figure 10. Diagnostic Labs Case Studies
Figure 11. Diagnostic Biomarkers Report Years Considered
Figure 12. Global Diagnostic Biomarkers Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Diagnostic Biomarkers Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Diagnostic Biomarkers Market Share by Region: 2022 VS 2033
Figure 15. Global Diagnostic Biomarkers Market Share by Players in 2022
Figure 16. Global Top Diagnostic Biomarkers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Biomarkers as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Diagnostic Biomarkers Revenue in 2022
Figure 18. North America Diagnostic Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Diagnostic Biomarkers Market Share by Type (2018-2033)
Figure 20. North America Diagnostic Biomarkers Market Share by Application (2018-2033)
Figure 21. North America Diagnostic Biomarkers Market Share by Country (2018-2033)
Figure 22. United States Diagnostic Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Diagnostic Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Diagnostic Biomarkers Market Size YoY (2018-2033) & (US$ Million)
Figure 25. Europe Diagnostic Biomarkers Market Share by Type (2018-2033)
Figure 26. Europe Diagnostic Biomarkers Market Share by Application (2018-2033)
Figure 27. Europe Diagnostic Biomarkers Market Share by Country (2018-2033)
Figure 28. Germany Diagnostic Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. France Diagnostic Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. U.K. Diagnostic Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Italy Diagnostic Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Russia Diagnostic Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Nordic Countries Diagnostic Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. China Diagnostic Biomarkers Market Size YoY (2018-2033) & (US$ Million)
Figure 35. China Diagnostic Biomarkers Market Share by Type (2018-2033)
Figure 36. China Diagnostic Biomarkers Market Share by Application (2018-2033)
Figure 37. Asia Diagnostic Biomarkers Market Size YoY (2018-2033) & (US$ Million)
Figure 38. Asia Diagnostic Biomarkers Market Share by Type (2018-2033)
Figure 39. Asia Diagnostic Biomarkers Market Share by Application (2018-2033)
Figure 40. Asia Diagnostic Biomarkers Market Share by Region (2018-2033)
Figure 41. Japan Diagnostic Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. South Korea Diagnostic Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. China Taiwan Diagnostic Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Southeast Asia Diagnostic Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. India Diagnostic Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Australia Diagnostic Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Diagnostic Biomarkers Market Size YoY (2018-2033) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Diagnostic Biomarkers Market Share by Type (2018-2033)
Figure 49. Middle East, Africa, and Latin America Diagnostic Biomarkers Market Share by Application (2018-2033)
Figure 50. Middle East, Africa, and Latin America Diagnostic Biomarkers Market Share by Country (2018-2033)
Figure 51. Brazil Diagnostic Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Mexico Diagnostic Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Turkey Diagnostic Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Saudi Arabia Diagnostic Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Israel Diagnostic Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. GCC Countries Diagnostic Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Qiagen N.V. Revenue Growth Rate in Diagnostic Biomarkers Business (2018-2023)
Figure 58. Perkinelmer, Inc. Revenue Growth Rate in Diagnostic Biomarkers Business (2018-2023)
Figure 59. Merck Millipore Revenue Growth Rate in Diagnostic Biomarkers Business (2018-2023)
Figure 60. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Diagnostic Biomarkers Business (2018-2023)
Figure 61. Enzo Biochem, Inc. Revenue Growth Rate in Diagnostic Biomarkers Business (2018-2023)
Figure 62. EKF Diagnostics Holdings, Inc. Revenue Growth Rate in Diagnostic Biomarkers Business (2018-2023)
Figure 63. Meso Scale Diagnostics, LLC. Revenue Growth Rate in Diagnostic Biomarkers Business (2018-2023)
Figure 64. Biosims Technologies Sas Revenue Growth Rate in Diagnostic Biomarkers Business (2018-2023)
Figure 65. Cisbio Bioassays Revenue Growth Rate in Diagnostic Biomarkers Business (2018-2023)
Figure 66. Signosis, Inc Revenue Growth Rate in Diagnostic Biomarkers Business (2018-2023)
Figure 67. Banyan Biomarkers, Inc Revenue Growth Rate in Diagnostic Biomarkers Business (2018-2023)
Figure 68. Biomedical Corp Revenue Growth Rate in Diagnostic Biomarkers Business (2018-2023)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices